Protein Expression Market Report Size, Trends & Growth Opportunity, By Product Type, By Application, By Services, By End User, By Region and forecast till 2027
A technique in which proteins are synthesized, modified and regulated in living organism is called as Protein expression. To study for the presence of one or more proteins in the cell or tissue, Protein expression is used.
Moreover, the biotechnology-based organizations have formed a big opportunity for the protein expression market growth by developing innovative therapeutics with nominal side effects.
Asia Pacific is anticipated to grow at the highest rate in the market due to high incidence of chronic diseases, rising public and private investments, and increase in life sciences research.
In 2020, Merck announced plans for the construction of a new biotech development facility in Switzerland. The company will be investing USD 282.5 million for this purpose. This facility is going to strengthen the company’s presence in the protein expression market.
In 2019, Agilent Technologies acquired BioTek Instruments (US). This acquisition expanded Agilent’s presence and expertise in cell analysis and strengthened its position in the growing immune-oncology and immunotherapy areas.
Global Protein Expression Market
The global protein expression market size is projected to reach USD 4.1 billion by 2027 from USD 2.2 billion in 2020, at a CAGR of 13.2% between 2020 and 2027.A technique in which proteins are synthesized, modified and regulated in living organism is called as Protein expression. To study for the presence of one or more proteins in the cell or tissue, Protein expression is used.
Market Drivers
The factors that drive the growth of the protein expression market comprises rise in geriatric population, age-related diseases and rise in prevalence of chronic diseases like cancer.Moreover, the biotechnology-based organizations have formed a big opportunity for the protein expression market growth by developing innovative therapeutics with nominal side effects.
Market Restraints
The key restraining factors of the growth of the protein expression market are Higher cost of the research and development, and complex government approval processes. The intricacies concerning the membrane protein expression and purification are also the challenging factors for the growth of the market.Market Segmentation
Protein Expression Marketsis segmented into major 4 categories. Based on Product Type, the market is segmented into Competent Cells, Expression Vectors, Reagents and Instruments. Based on Services, the market is segmented into Antibody Development & Production, Protein Expression & Production, Hybridoma One-Stop Services, Stable Cell Line Development and Bioanalytical Assay Services. Based on Application, the market is segmented into Research, Therapeutic and Industrial. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East.Regional Analysis
North America, followed by Europe, has the highest market share for protein expression because of the high investments in research and development activities and rising involvement of pharmaceuticals and biotechnology companies in the protein expression market.Asia Pacific is anticipated to grow at the highest rate in the market due to high incidence of chronic diseases, rising public and private investments, and increase in life sciences research.
Market Key Players
Some of the key players operating in Global Protein Expression Market are Thermo Fisher Scientific, Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Domainex, Biomatik, Syngene, Accelagen Inc., R&D Systems, Inc., Enzo Life Sciences, Inc.Industry development
In 2020, Thermo Fisher Scientific Inc. acquired the biotechnology company, Qiagen (Germany). This acquisition will help Thermo Fisher Scientific to enhance its precision medicine portfolio through molecular diagnostics and improved life sciences solutions.In 2020, Merck announced plans for the construction of a new biotech development facility in Switzerland. The company will be investing USD 282.5 million for this purpose. This facility is going to strengthen the company’s presence in the protein expression market.
In 2019, Agilent Technologies acquired BioTek Instruments (US). This acquisition expanded Agilent’s presence and expertise in cell analysis and strengthened its position in the growing immune-oncology and immunotherapy areas.
Frequently Asked Questions about the Protein Expression Market
What is the estimated value of the Protein Expression Market?
What is the growth rate of the Protein Expression Market?
What is the forecasted size of the Protein Expression Market?
Who are the key companies in the Protein Expression Market?
Report Attribute | Details |
---|---|
Published | February 2022 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD
| USD 24.3 Billion |
Forecasted Market Value ( USD
| USD 37 Billion |
Compound Annual Growth Rate | 6.2% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |
Table of Contents
1 Introduction
2 Research Methodology
4 Protein Expression Market Outlook
5 Network Security Market, By Product Type
6 Network Security Market, By Services
7 Network Security Market, By End User
8 Network Security Market, By Application
9 Network Security Market, By Region
10 North America Protein Expression Market Analysis and Forecast (2021-2027)
11 Europe Protein Expression Market Analysis and Forecast (2021-2027)
12 Asia Pacific Protein Expression Market Analysis and Forecast (2021-2027)
13 Latin America Protein Expression Market Analysis and Forecast (2021-2027)
14 Middle East Protein Expression Market Analysis and Forecast (2021-2027)
15 Competitive Analysis
16 Company Profiles
Companies Mentioned
- Thermo Fisher Scientific
- Merck KGaA
- Promega Corporation
- Agilent Technologies Inc.
- Domainex
- Biomatik
- Syngene
- Accelagen Inc.
- R&D Systems Inc.
- Enzo Life Sciences Inc.